Disc Medicine Inc at JPMorgan Healthcare Conference Transcript
&-
Good afternoon and welcome to the 42nd Annual JPMorgan Healthcare Conference. My name is [Dave Praharaj] and I'm part of the healthcare investment banking team here at JPMorgan. Today, I have the pleasure of introducing our speaker, John Quisel, CEO of Disc Medicine. In terms of logistics, Please reserve any questions for after the presentation, We will be passing around the mic. with that, take it away, John.
Great, thank you. Good to see you all. Good afternoon. So here, Disc Medicine, we are a hematology-focused drug development company and 2023 was a remarkable year for us. It was our 1st year as a publicly listed company trading on Nasdaq under the symbol IRON. And our stock price was up over 200% on the year.
And most importantly, that was achieved because of all of the execution efforts from the team developing three clinical-stage assets across a wide range of clinical trials. Two of those lead programs began showing us signs of really
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |